Shared decision-making for gene therapy in haemophilia care

1. Athale A, Giguere A, Barbara A, Krassova S, Iorio A. Developing a two-sided intervention to facilitate shared decision-making in haemophilia: decision boxes for clinicians and patient decision aids for patients. Haemophilia. 2014 Nov;20(6):800-6. Athale A Giguere A Barbara A Krassova S Iorio A . Developing a two-sided intervention to facilitate shared decision-making in haemophilia: decision boxes for clinicians and patient decision aids for patients . Haemophilia . 2014 Nov ; 20 ( 6 ): 800 - 6 . Search in Google Scholar

2. Valentino LA, Blanchette V, Negrier C, O’Mahoney B, Vias V, Sannie T, Skinner M. Personalising haemophilia management with shared decision making. J Haem Pract 2021; 8(1) 69-79. doi:10.17225/jhp/00178 Valentino LA Blanchette V Negrier C O’Mahoney B Vias V Sannie T Skinner M . Personalising haemophilia management with shared decision making . J Haem Pract 2021 ; 8 ( 1 ) 69 - 79 . doi: 10.17225/jhp/00178 Open DOISearch in Google Scholar

3. Bomhof-Roordink H, Gärtner FR, Stiggelbout AM, Pieterse AR. Key components of shared decision making models: a systematic review. BMJ Open 2019; 9: e031763. doi: 10.1136/bmj.open-2019-031763. Bomhof-Roordink H Gärtner FR Stiggelbout AM Pieterse AR . Key components of shared decision making models: a systematic review . BMJ Open 2019 ; 9 : e031763 . doi: 10.1136/bmj.open-2019-031763 . Open DOISearch in Google Scholar

4. Légaré F, Härter M, Stiggelbout AM, Thomson R, Stacey D. Choosing treatments and the role of shared decision-making. In: North J, Nolte E, Merkur S, Anell a (eds.), Achieving Person-Centred Health Systems: Evidence, Strategies and Challenges. 2020. Cambridge: Cambridge University Press. 283-316. doi: 10.1017/9781108855464.014. Légaré F Härter M Stiggelbout AM Thomson R Stacey D . Choosing treatments and the role of shared decision-making . In: North J Nolte E Merkur S Anell a (eds.), Achieving Person-Centred Health Systems: Evidence, Strategies and Challenges . 2020 . Cambridge : Cambridge University Press . 283 - 316 . doi: 10.1017/9781108855464.014 . Open DOISearch in Google Scholar

5. Charles C, Gafni A, Whelan A. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999; 49(5): 651-61. doi: 10.1016/s0277-9536(99)00145-8. Charles C Gafni A Whelan A . Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model . Soc Sci Med 1999 ; 49 ( 5 ): 651 - 61 . doi: 10.1016/s0277-9536(99)00145-8 . Open DOISearch in Google Scholar

6. National Institute for Health and Care Excellence. Shared decision making. NICE guideline [NG197]. Published 17 June 2021. Available from https://www.nice.org.uk/guidance/ng197 (accessed July 2023). National Institute for Health and Care Excellence . Shared decision making . NICE guideline [NG197] . Published 17 June 2021 . Available from https://www.nice.org.uk/guidance/ng197 ( accessed July 2023 ). Search in Google Scholar

7. Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ 2017; 359: j4891. doi: 10.1136/bmj.j4891. Elwyn G Durand MA Song J . A three-talk model for shared decision making: multistage consultation process . BMJ 2017 ; 359 : j4891 . doi: 10.1136/bmj.j4891 . Open DOISearch in Google Scholar

8. Srivastava A, Santagostino E, Dougall A, et al.; WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26 Suppl 6:1-158. doi: 10.1111/hae.14046. Srivastava A Santagostino E Dougall A .; WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia , 3rd edition . Haemophilia 2020 ; 26 Suppl 6: 1 - 158 . doi: 10.1111/hae.14046 . Open DOISearch in Google Scholar

9. Mühlbacher AC, Sadler A, Lamprecht B, Juhnke C. Patient preferences in the treatment of hemophilia A: A Best-Worst Scaling Case 3 analysis. Value Health 2020 Jul;23(7):862-869. doi: 10.1016/j.jval.2020.02.013. Mühlbacher AC Sadler A Lamprecht B Juhnke C . Patient preferences in the treatment of hemophilia A: A Best-Worst Scaling Case 3 analysis . Value Health 2020 Jul ; 23 ( 7 ): 862 - 869 . doi: 10.1016/j.jval.2020.02.013 . Open DOISearch in Google Scholar

10. Coppola A, Franchini M, Pappagallo G, et al. Current choices and management of treatment in persons with severe hemophilia A without inhibitors: a mini-Delphi consensus. J Clin Med 2022; 11(3): 801. doi: 10.3390/jcm11030801. Coppola A Franchini M Pappagallo G . Current choices and management of treatment in persons with severe hemophilia A without inhibitors: a mini-Delphi consensus . J Clin Med 2022 ; 11 ( 3 ): 801 . doi: 10.3390/jcm11030801 . Open DOISearch in Google Scholar

11. Fletcher S, Jenner K, Holland M, Khair K. The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me. Health Expect 2022; 25(1): 443-454. doi: 10.1111/hex.13404. Fletcher S Jenner K Holland M Khair K . The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me . Health Expect 2022 ; 25 ( 1 ): 443 - 454 . doi: 10.1111/hex.13404 . Open DOISearch in Google Scholar

12. Gualtierotti R, Pasca S, Ciavarella A, et al. Updates on novel non-replacement drugs for hemophilia. Pharmaceuticals (Basel) 2022; 15(10): 1183. doi: 10.3390/ph15101183.. Gualtierotti R Pasca S Ciavarella A . Updates on novel non-replacement drugs for hemophilia . Pharmaceuticals (Basel) 2022 ; 15 ( 10 ): 1183 . doi: 10.3390/ph15101183 .. Open DOISearch in Google Scholar

13. Gogia P, Tarantino M, Schramm W, Aledort L. New directions to develop therapies for people with hemophilia. Expert Rev Hematol 2023 Mar 8:1-17. doi: 10.1080/17474086.2023.2184341. Epub ahead of print. Gogia P Tarantino M Schramm W Aledort L . New directions to develop therapies for people with hemophilia . Expert Rev Hematol 2023 Mar 8 : 1 - 17 . doi: 10.1080/17474086.2023.2184341 . Epub ahead of print. Open DOISearch in Google Scholar

14. Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev 2022; 52: 100890. doi: 10.1016/j.blre.2021.100890. Hermans C Noone D Benson G . Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians . Blood Rev 2022 ; 52 : 100890 . doi: 10.1016/j.blre.2021.100890 . Open DOISearch in Google Scholar

15. Scalone L, Mantovani LG, Borghetti F, Von Mackensen S, Gringeri A. Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study. Haemophilia 2009; 15(2): 473-86. doi: 10.1111/j.1365-2516.2008.01926.x. Scalone L Mantovani LG Borghetti F Von Mackensen S Gringeri A . Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study . Haemophilia 2009 ; 15 ( 2 ): 473 - 86 . doi: 10.1111/j.1365-2516.2008.01926.x . Open DOISearch in Google Scholar

16. Woollard L, Gorman R, Rosenfelt DJ. Addressing patient education priorities in the era of gene therapy for haemophilia: Towards evidence-informed shared decision-making. Haemophilia 2021; 27(2): e302-e304. doi: 10.1111/hae.14214. Woollard L Gorman R Rosenfelt DJ . Addressing patient education priorities in the era of gene therapy for haemophilia: Towards evidence-informed shared decision-making . Haemophilia 2021 ; 27 ( 2 ): e302 - e304 . doi: 10.1111/hae.14214 . Open DOISearch in Google Scholar

17. Leebeek FWG, Miesbach W. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Blood. 2021 Sep 16;138(11):923-931 Leebeek FWG Miesbach W . Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues . Blood . 2021 Sep 16 ; 138 ( 11 ): 923 - 931 Search in Google Scholar

18. Miesbach W, Foster GR, Peyvandi F. Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists. J Hepatol 2023; 78(3): 467-470. doi: 10.1016/jhep.2022.11.014. Miesbach W Foster GR Peyvandi F . Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists . J Hepatol 2023 ; 78 ( 3 ): 467 - 470 . doi: 10.1016/jhep.2022.11.014 . Open DOISearch in Google Scholar

19. Wang M, Negrier C, Driessler F, Goodman C, Skinner MW. The hemophilia gene therapy patient journey: questions and answers for shared decision-making. Patient Prefer Adherence 2022; 16: 1439-1447. doi: 10.2147/PPA.S355627. Wang M Negrier C Driessler F Goodman C Skinner MW . The hemophilia gene therapy patient journey: questions and answers for shared decision-making . Patient Prefer Adherence 2022 ; 16 : 1439 - 1447 . doi: 10.2147/PPA.S355627 . Open DOISearch in Google Scholar

20. Limjoco J, Calatroni A, Aristizabal P, Thornburg CD. Gene therapy preferences and informed decision-making: Results from a National Hemophilia Foundation Community Voices in Research survey. Haemophilia 2023; 29 (1): 51-60. doi: 10.1111/hae.14706. Limjoco J Calatroni A Aristizabal P Thornburg CD . Gene therapy preferences and informed decision-making: Results from a National Hemophilia Foundation Community Voices in Research survey . Haemophilia 2023 ; 29 ( 1 ): 51 - 60 . doi: 10.1111/hae.14706 . Open DOISearch in Google Scholar

21. Noone D, Astermark J, O’Mahoney B, et al. The journey of gene therapy in haemophilia – putting the patient at the centre of the hub and spoke model. J Haem Pract 2022; 9(1): 156-166. doi10.2478/jhp-2002-0021. Noone D Astermark J O’Mahoney B . The journey of gene therapy in haemophilia – putting the patient at the centre of the hub and spoke model . J Haem Pract 2022 ; 9 ( 1 ): 156 - 166 . doi 10.2478/jhp-2002-0021 . Open DOISearch in Google Scholar

22. Fletcher S, Jenner K, Holland M, Chaplin S, Khair K. An exploration of why men with severe haemophilia might not want gene therapy: The Exigency study. Haemophilia 2021; 27(5): 760-768. doi: 10.1111/hae.14378. Fletcher S Jenner K Holland M Chaplin S Khair K . An exploration of why men with severe haemophilia might not want gene therapy: The Exigency study . Haemophilia 2021 ; 27 ( 5 ): 760 - 768 . doi: 10.1111/hae.14378 . Open DOISearch in Google Scholar

23. Valentino LA, Kaczmarek R, Pierce GF, Noone D, O’Mahoney B, Page D, Rotellini D, Skinner MW. Hemophilia gene therapy: First do no harm. J Thromb Haemost 2023 June 21. doi: 10.1016/j.tha.2023.06.016. [Epub ahead of print]. Valentino LA Kaczmarek R Pierce GF Noone D O’Mahoney B Page D Rotellini D Skinner MW . Hemophilia gene therapy: First do no harm . J Thromb Haemost 2023 June 21 . doi: 10.1016/j.tha.2023.06.016 . [Epub ahead of print]. Open DOISearch in Google Scholar

24. Savioni L, Triberti S. Cognitive biases in chronic illness and their impact on patients’ commitment. Front Psychol 2020; 11: 579455. doi: 10.3389/fpsyg.2020.579455. Savioni L Triberti S . Cognitive biases in chronic illness and their impact on patients’ commitment . Front Psychol 2020 ; 11 : 579455 . doi: 10.3389/fpsyg.2020.579455 . Open DOISearch in Google Scholar

25. Khair K, Steadman L, Chaplin S, et al. Parental perspectives on gene therapy for children with haemophilia: The Exigency study. Haemophilia 2020; 27(1): 120-128. doi: 10.1111. Khair K Steadman L Chaplin S . Parental perspectives on gene therapy for children with haemophilia: The Exigency study . Haemophilia 2020 ; 27 ( 1 ): 120 - 128 . doi: 10.1111 . Open DOISearch in Google Scholar

26. Politi MC, Dizon DS, Frosch DL, Kuzemchak MD, Stiggelbout AM. Importance of clarifying patients’ desired role in shared decision making to match their level of engagement with their preferences. BMJ 2013; 347: f7066. doi: 10.1136/bmj.f7066. Politi MC Dizon DS Frosch DL Kuzemchak MD Stiggelbout AM . Importance of clarifying patients’ desired role in shared decision making to match their level of engagement with their preferences . BMJ 2013 ; 347 : f7066 . doi: 10.1136/bmj.f7066 . Open DOISearch in Google Scholar

27. The SHARE Approach. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/health-literacy/professional-training/shared-decision/index.html (last accessed March 2023). The SHARE Approach . Agency for Healthcare Research and Quality , Rockville, MD . https://www.ahrq.gov/health-literacy/professional-training/shared-decision/index.html ( last accessed March 2023 ). Search in Google Scholar

28. Nossair F, Thornburg CD. The role of patient and healthcare professionals in the era of new haemophilia treatments in developed and developing countries. Ther Adv Hematol 2018; 9(8): 239-249. doi: 10.1177/2040620718784830. Nossair F Thornburg CD . The role of patient and healthcare professionals in the era of new haemophilia treatments in developed and developing countries . Ther Adv Hematol 2018 ; 9 ( 8 ): 239 - 249 . doi: 10.1177/2040620718784830 . Open DOISearch in Google Scholar

29. Limjoco J, Thornburg CD. Gene therapy for hemophilia A: A mixed methods study of patient preferences and shared decision-making. Patient Prefer Adherence 2023 Apr 19;17:1093-1105. doi: 10.2147/PPA.S406894. Limjoco J Thornburg CD . Gene therapy for hemophilia A: A mixed methods study of patient preferences and shared decision-making . Patient Prefer Adherence 2023 Apr 19 ; 17 : 1093 - 1105 . doi: 10.2147/PPA.S406894 . Open DOISearch in Google Scholar

30. Limjoco J, Thornburg CD. Development of a haemophilia A gene therapy shared decision-making tool for clinicians. Haemophilia 2023 July 4. doi: 10.1111/hae.14822. Epub ahead of print. Limjoco J Thornburg CD . Development of a haemophilia A gene therapy shared decision-making tool for clinicians . Haemophilia 2023 July 4 . doi: 10.1111/hae.14822 . Epub ahead of print. Open DOISearch in Google Scholar

31. Noone D, Chadwick J, Coffin D, Hayes B, Kaeser G, Naccache M, Skinner M, Sannie T, Thornburg C, Pierce G. A new tool to assist in treatment selection – the World Federation of Hemophilia (WFH) shared decision making (SDM) tool. Presented at ISTH 2023 (in press). Noone D Chadwick J Coffin D Hayes B Kaeser G Naccache M Skinner M Sannie T Thornburg C Pierce G . A new tool to assist in treatment selection – the World Federation of Hemophilia (WFH) shared decision making (SDM) tool . Presented at ISTH 2023 (in press). Search in Google Scholar

32. Fletcher S, Jenner K, Holland M, Khair K. Expectation and loss when gene therapy for haemophilia is not an option: An Exigency sub-study. Haemophilia 2023; 29(3): 776-783. doi: 10.1111/hae.14774. Fletcher S Jenner K Holland M Khair K . Expectation and loss when gene therapy for haemophilia is not an option: An Exigency sub-study . Haemophilia 2023 ; 29 ( 3 ): 776 - 783 . doi: 10.1111/hae.14774 . Open DOISearch in Google Scholar